Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly L Bolton

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Journal of the National Cancer Institute|March 24, 2010
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalElizabeth M Azzato, Jonathan Tyrer, Peter A Fasching, et al.
Nature Genetics|October 27, 2020
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L Bolton, Ryan N Ptashkin, Teng Gao, et al.
Nature Communications|May 21, 2026
Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia riskKara M Barnao, Aubrey K Hubbard, Irenaeus C C Chan, et al.
Nature Medicine|August 5, 2020
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
JAMA|January 26, 2012
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancerKelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Nature Genetics|August 4, 2009
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2Honglin Song, Susan J Ramus, Jonathan Tyrer, et al.
Nature|June 11, 2024
The Space Omics and Medical Atlas (SOMA) and international astronaut biobankEliah G Overbey, JangKeun Kim, Braden T Tierney, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Journal of the National Cancer Institute|March 24, 2010
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalElizabeth M Azzato, Jonathan Tyrer, Peter A Fasching, et al.
Nature Genetics|October 27, 2020
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L Bolton, Ryan N Ptashkin, Teng Gao, et al.
Nature Communications|May 21, 2026
Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia riskKara M Barnao, Aubrey K Hubbard, Irenaeus C C Chan, et al.
Nature Medicine|August 5, 2020
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
JAMA|January 26, 2012
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancerKelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Nature Genetics|August 4, 2009
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2Honglin Song, Susan J Ramus, Jonathan Tyrer, et al.
Nature|June 11, 2024
The Space Omics and Medical Atlas (SOMA) and international astronaut biobankEliah G Overbey, JangKeun Kim, Braden T Tierney, et al.
Pageof 7